The global market hit over $53 billion in 2024, and depending on which analyst report youre reading, projections suggest we could be looking at $165 billion by the early 2030s
Wei J, Wang B, Wang H, Meng L, Zhao Q, Li X, et al
With such robust appetite suppression and high rates of reported weight loss, like 76.7% of patients achieving their stated weight loss goal, it foreshadows a drug that may become a first-line option in obesity pharmacotherapy
In vitro pituitary studies demonstrate higher GH release compared to individual peptide exposure
Knowing which form is actually in the bottle matters more than anything else when shopping for the best copper peptide serum